ShadowBuys
Sign inJoin for free

Rep. Josh Gottheimer sold Halozyme Therapeutics (HALO)

Rep. Josh Gottheimer (D-NJ-5) · $1K–$15K · traded Sep 9, 2024

Transaction
Sold (partial)
Amount
$1K–$15K
Owner
Joint
Traded
Sep 9, 2024
Disclosed
Oct 3, 2024
Days to disclose
24
Asset type
Stock
As filed
Halozyme Therapeutics, Inc. - Common Stock
Industry
Biotechnology · Healthcare
Official filing ↗All of Gottheimer's tradesAll Congress trades in HALO

Other trades in this filing

All of Gottheimer's trades →

Recent Congress trades in HALO

Company context for HALO

Recent records for the company. These may have been published before or after this trade; compare the dates before drawing a connection.

  1. HALOFinancial report·SEC EDGAR

    HALO: 10-Q financial filing

    Filed 10-Q for an event or period dated 2026-09-30. Read the company report for its disclosures.

    Public: Nov 5, 2026, 4:13 PM ESTEvent / period: Sep 30, 2026Original source ↗
  2. HALOCompany announcement·SEC EDGAR

    HALO: Financial results

    Filed 8-K for an event or period dated 2026-11-05. Financial results.

    Public: Nov 5, 2026, 4:08 PM ESTEvent / period: Nov 5, 2026Original source ↗
  3. HALOAmended filing·SEC EDGAR

    HALO: amended insider filing

    An amended ownership report was filed. Read the original and amendment before comparing transactions.

    Public: Oct 8, 2026, 7:55 PM EDTEvent / period: May 5, 2026Original source ↗

From a periodic transaction report filed under the STOCK Act. Amounts are the ranges members report. Nothing here is investment advice.